Nurse Practitioner in Oakley, KS Accepting Medicare
8 Nurse Practitioner nurses found. Showing 1 - 8
 Jessica Renee Catlin, FNP-BC Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 211 Cherry Ave, Oakley, KS 67748 Phone: 785-672-3211 Fax: 785-672-8184 |
Tara Lynn Powell, DNP, APRN, CPNP-PC Nurse Practitioner - Pediatrics Medicare: Medicare Enrolled Practice Location: 212 Maple Ave, Oakley, KS 67748 Phone: 785-672-3261 |
Kerri Deann Kaus, ARNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 212 Maple Ave, Oakley, KS 67748 Phone: 785-672-3281 Fax: 785-672-8184 |
Lynelle A Fossum, ARNP Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 212 Maple Ave, Oakley, KS 67748 Phone: 785-672-3261 Fax: 785-672-8194 |
Jonna K Inman, ARNPC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 212 Maple Ave, Oakley, KS 67748 Phone: 785-672-3261 Fax: 785-672-8194 |
Megan Baalman, APRN Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 212 Maple Ave, Oakley, KS 67748 Phone: 785-672-3261 |
 Mr. Kyle Lacy Hodges, APRN-FNP Nurse Practitioner - Primary Care Medicare: Accepting Medicare Assignments Practice Location: 212 Maple Ave, Oakley, KS 67748 Phone: 785-672-3261 Fax: 785-672-8194 |
Julie Ann Juenemann, APRN Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 1001 Highway 40 Ste 4, Oakley, KS 67748 Phone: 785-672-1441 Fax: 785-671-1060 |
News Archive
Smart Disc issued patent for artificial spinal disc technology
Smart Disc, Inc., a Michigan-based medical technology company focused on the development of new and innovative spine products, announced today that it has been awarded Patent US 7,407,513 B2 for Smart Disc's unique artificial spinal disc technology.
Engaging in physical activity not going to put at greater risk of knee osteoarthritis
Adults age 45 and older who engaged in moderate physical activity up to two and a half hours a week did not increase their risk of developing knee osteoarthritis over a 6-year follow-up period, a new study finds.
ChemGenex's Omacetaxine to be showcased in three oral oresentations at EHA
ChemGenex Pharmaceuticals Limited announced today that new data from two clinical studies and one pre-clinical study with omacetaxine will be presented at oral sessions during the forthcoming 14th Congress of the European Hematology Association (EHA) in Berlin, Germany.
Clemson study provides insight into role of fungi in early childhood dental health
Although mostly preventable, tooth decay is one of the most common chronic diseases in children worldwide, particularly in developing countries. If left untreated, cavities can be painful and may negatively affect a young child's overall health, development and quality of life.
› Verified 6 days ago